Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Hypertension Products Recalled
03/29/2019
Multiple firms have announced new recalls of losartan products because the carcinogenic substance N-nitrosodimethylamine was identified in an active pharmaceutical ingredient used to manufacture the drug.
Multiple firms have announced new recalls of losartan products because the carcinogenic substance N-nitrosodimethylamine was identified in an active pharmaceutical ingredient used to manufacture the drug.
Multiple firms have announced...
03/29/2019
Pharmacy Learning Network

Advertisement

News
Additional Hypertension Meds Pulled
03/29/2019
More valsartan products are being recalled after trace amounts of a carcinogenic substance were found in an active pharmaceutical ingredient used to manufacture the products.
More valsartan products are being recalled after trace amounts of a carcinogenic substance were found in an active pharmaceutical ingredient used to manufacture the products.
More valsartan products are...
03/29/2019
Pharmacy Learning Network
News
Dermatologists and Pharmacists Have Differing Views of Topical Steroids
03/28/2019
Researchers found it wasn't uncommon for pharmacists' recommendations to contradict doctors' instructions, according to a recent report.
Researchers found it wasn't uncommon for pharmacists' recommendations to contradict doctors' instructions, according to a recent report.
Researchers found it wasn't...
03/28/2019
Pharmacy Learning Network
News
Hospital Pharmacists Face Dozens of Drug Shortages Yearly
03/27/2019
According to a recent study, pharmacists said they had less than a month of warning about dwindling supplies before they had to manage an active drug shortage.
According to a recent study, pharmacists said they had less than a month of warning about dwindling supplies before they had to manage an active drug shortage.
According to a recent study,...
03/27/2019
Pharmacy Learning Network

Advertisement

News
Many Eligible Patients Are Never Offered Statins
03/27/2019
According to a recent study, statin-eligible patients report they have gone untreated because they have never been offered statins.
According to a recent study, statin-eligible patients report they have gone untreated because they have never been offered statins.
According to a recent study,...
03/27/2019
Pharmacy Learning Network
News
AHA Updates BP Measurement Guidance
03/27/2019
The American Heart Association has released an update to its 2005 statement on the measurement of blood pressure.
The American Heart Association has released an update to its 2005 statement on the measurement of blood pressure.
The American Heart Association...
03/27/2019
Pharmacy Learning Network
News
Long-Term Hormone Use After Menopause Tied to Alzheimer`s Risk
03/21/2019
Women who take hormone replacement therapy to ease menopause symptoms may be slightly more likely to develop Alzheimer's disease, a new study suggests.
Women who take hormone replacement therapy to ease menopause symptoms may be slightly more likely to develop Alzheimer's disease, a new study suggests.
Women who take hormone...
03/21/2019
Pharmacy Learning Network

Advertisement

News
FDA Allows Sale of Certain Blood Pressure Drugs Amid Shortage
03/20/2019
The FDA said it will temporarily allow certain manufacturers to sell blood pressure medications containing specified levels of a probable cancer-causing impurity in order to maintain adequate supplies of the drug.
The FDA said it will temporarily allow certain manufacturers to sell blood pressure medications containing specified levels of a probable cancer-causing impurity in order to maintain adequate supplies of the drug.
The FDA said it will temporarily...
03/20/2019
Pharmacy Learning Network
News
Class I Recall Issued for Injection
03/20/2019
The FDA has issued a recall for a prescription drug used to prevent the harmful effects of methotrexate used in cancer treatment.
The FDA has issued a recall for a prescription drug used to prevent the harmful effects of methotrexate used in cancer treatment.
The FDA has issued a recall for...
03/20/2019
Pharmacy Learning Network
News
Overactive Bladder Drug Recalled
03/20/2019
A prescription antispasmodic and anticholinergic medication used to treat frequent, urgent urination, urine leakage, and other symptoms of overactive bladder is being recalled.
A prescription antispasmodic and anticholinergic medication used to treat frequent, urgent urination, urine leakage, and other symptoms of overactive bladder is being recalled.
A prescription antispasmodic and...
03/20/2019
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use